NEW YORK (GenomeWeb) – The US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) has awarded up to $21.9 million to Diassess as part of a cost-share contract to advance development of flu diagnostic technology for use in physician offices and eventually consumers' homes, the company said today.